Thomas Ludwig
- Molecular Biology top 2%
- Oncology top 2%
- Cancer Research top 2%
- Genetics top 5%
- Immunology top 10%
- Topics
- DNA Repair Mechanisms (23 papers)CRISPR and Genetic Engineering (11 papers)BRCA gene mutations in cancer (9 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Thomas Ludwig
45 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Biology 2.5k
- Oncology 1.5k
- Cancer Research 670
- Genetics 466
- Immunology 379
Countries citing papers authored by Thomas Ludwig
This map shows the geographic impact of Thomas Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ludwig more than expected).
Fields of papers citing papers by Thomas Ludwig
This network shows the impact of papers produced by Thomas Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ludwig. The network helps show where Thomas Ludwig may publish in the future.
Co-authorship network of co-authors of Thomas Ludwig
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ludwig. A scholar is included among the top collaborators of Thomas Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ludwig. Thomas Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 3 | |
| 3 | 35 | |
| 4 | IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancerbreakdown → | 401 |
| 5 | 53 | |
| 6 | 85 | |
| 7 | 109 | |
| 8 | 41 | |
| 9 | 73 | |
| 10 | 57 | |
| 11 | 62 | |
| 12 | 11 | |
| 13 | 200 | |
| 14 | 36 | |
| 15 | 1 | |
| 16 | 14 | |
| 17 | 113 | |
| 18 | 10 | |
| 19 | 21 | |
| 20 | 119 |
About Thomas Ludwig
Thomas Ludwig is a scholar working on Oncology, Cancer Research and Aging, having authored 45 papers that have together received 3.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (23 papers), CRISPR and Genetic Engineering (11 papers) and BRCA gene mutations in cancer (9 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (670 citations) and Molecular Biology (2.5k citations). Thomas Ludwig has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Richard Baer, Yingming Zhao, Minjia Tan, Ning Kon, Wei Gu, Le Jiang, Tongyuan Li, Reena Shakya, Maria Jasin and Matthias Szabolcs. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.